Rex Hematology Oncology Associates-Cary — Cary, North Carolina

Rex Hematology Oncology Associates-Cary is a clinical research site located in Cary, North Carolina, United States 27518.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Rex Hematology Oncology Associates-Cary has participated in 12 clinical trials with 9 currently active.

Therapeutic areas: Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone.

Sponsors: NRG Oncology, SWOG Cancer Research Network, ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rex Hematology Oncology Associates-Cary?

Rex Hematology Oncology Associates-Cary has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rex Hematology Oncology Associates-Cary conducted?

Rex Hematology Oncology Associates-Cary has 12 clinical trials on record, with 9 currently active. Their work covers Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone.

Is Rex Hematology Oncology Associates-Cary accredited by Crixeo Health?

Yes — Rex Hematology Oncology Associates-Cary holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rex Hematology Oncology Associates-Cary?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.